Global Concussions Market Research Report Insight and Industry Analysis by Treatment (Diagnosis and Treatment) by End User (Hospitals and Clinics, Diagnostic Centers and Payers) & Region – Forecast till 2023
Concussions Market Overview
A concussion can be referred to as a mild traumatic brain injury, which disrupts the normal brain functioning temporarily and is caused by a jolt or blow to the head. Concussions are frequently occurring brain injuries which do not need medication or extensive care. The global concussions market, as per a report by Market Research Future (MRFR) is touted to register a CAGR of 3.22%, surpassing a valuation of USD 1,060.36 million during the forecast period (2015-2023). It can also occur from a hit to the body, which produces a reflex force to the head.
Get Free Sample Copy of Report @ https://www.marketresearchfuture.com/sample_request/5724
Surging prevalence of mild traumatic brain injuries, ever-increasing geriatric population, and ongoing product development and approval are some of the key factors likely to encourage the market growth in the foreseeable future. Big data plays a major role in traumatic brain injury. Efforts to enhance the clinical practice guidelines in order to predict the severity of concussions have led to the development of algorithms, which evaluate changes in cognitive, physical, neuropsychological, and behavioral levels. The increasing data availability and analytical capabilities will further create opportunities to use big data analytics in traumatic brain injuries. Thus, the introduction of big data has encouraged the concussions market growth across the globe.
On the contrary, strict regulatory mandates and the dearth of trained professionals across the globe are estimated to deter the market growth in the coming years.
Concussions Market Competitive Dashboard
The top players operating in the concussions market include
- Integra LifeSciences Corporation
- Teva Pharmaceutical Industries Ltd
- Sun Pharmaceutical Industries Ltd
- Medtronic PLC
- Zydus Cadila
- Lupin
- Mylan NV
- Pfizer Inc.
- Sanofi SA
- Novartis AG
Global Concussions Market: Segmental Analysis
The concussions market has been segmented on the basis of treatment and end users.
By treatment, the market is segmented into diagnosis and treatment. Of these, the diagnosis segment was valued at 818.09 USD million in 2017 due to the high prevalence of traumatic brain injury across the globe.
The end users segment comprises diagnostic centers, hospital and clinics, and payers. Of these, the hospital & clinics segment is likely to gain prominence due to favorable reimbursement policies and the presence of advanced healthcare equipment.
Concussions Market Regional Frontiers
Geographically, the concussions market spans across the Asia Pacific, Europe, the Americas, and the Middle East & Africa.
Considering the global scenario, the Americas is predicted to register the most significant growth in the global market, mainly due to the rising prevalence of concussions in the region. The rising awareness created by private firms and government organizations is further encouraging the market growth in the region.
Europe has managed to seize the second-largest share globally due to the rising cases of concussions. The growth can be credited to the rising initiatives by private and public firms like introduction of new guidelines for the management of concussions.
Meanwhile, the Asia Pacific is estimated to expand at the fastest pace, mainly due to the improving healthcare infrastructure along with the rising disposable income of the population. The surge in improved healthcare facilities has further promised a high level of research activities, which has influenced the market positively. The increased incidence of traumatic brain injuries has encouraged the market growth globally.
Concussions Industry Updates
September 2019: Aurora Concussion Therapy Systems, Inc. involved in the development of non-invasive medical device in order to treat brain trauma and concussions has declared that the US FDA has designated Aurora Light Therapy System device as a breakthrough device under its Expedited Access Pathway. The aim of this program is to provide healthcare providers and patients with timely access to medical devices by speeding up their assessment, development, and review procedures.
TABLE OF CONTENTS
1 Executive Summary$ 1,350.00
2 Market Introduction$ 0.00
2.1 Definition 18
2.2 Scope Of The Study 18
2.3 Market Structure 18
3 Research Methodology$ 0.00
3.1 Research Process 19
3.2 Primary Research 20
3.3 Secondary Research 21
3.4 Market Size Estimation 22
3.5 Forecast Model 22
4 Market Dynamics$ 950.00
4.1 Overview 23
4.2 Drivers 23
4.2.1 Increasing Incidence Of Mild Traumatic Brain Injuries 24
4.2.2 Ongoing Product Development And Approval 24
4.2.3 Growing Geriatric Population 24
4.3 Restraints 25
4.3.1 Stringent Regulatory Framework 25
4.3.2 Shortage Of Trained Professionals 25
4.4 Opportunities 25
4.4.1 Growing Awareness About Concussions 25
5 Market Factor Analysis
…Continued
Browse Complete Premium Research Report Enabled with Detailed TOC at https://www.marketresearchfuture.com/reports/concussions-market-5724
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.
In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.
Contact:
Akash Anand
Market Research Future
+1 646 845 9312
